ClinicalTrials.gg
CompletedNCT04086056CraNIRSUpdated Feb 21, 2024

CraNIRS Clinical Study

An observational study in Craniosynostoses, sponsored by Hospices Civils de Lyon. Completed at 1 site in France. Open to participants aged 3 Months to 18 Months. Per ClinicalTrials.gov, last updated 2024-02-21.

Sponsored by Hospices Civils de Lyon · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
40
Ages
3 Months to 18 Months
Sex
All
01

Study summary

Craniosynostosis is a rare disorder characterized by a premature fusion of one or more sutures of the skull. Craniosynostosis is usually diagnosed in the first years of life. Several complications may be identified if untreated, notably, developmental delay, and vision problems.

In some patients with craniosynostosis a decrease in cerebral blood perfusion can be identified. It might be related to the constriction of the brain caused by premature sutural fusion or the localized constriction of venous sinuses.

In this study the investigator use the NIRS which is defined as a non-invasive technique to monitor hemodynamic parameters and hemoglobin oxygen saturation of the brain during the surgical correction of the craniosynostosis. By applying this method the investigator will be able to analyse the changes in cerebral hemoglobin oxygen saturation related to the modification of the skull.

Determining changes in brain oxygen saturation by using NIRS before, during and after surgery will help both to better understanding the impact of surgical decompression on improving cerebral oxygenation and to better adapt anaesthesia strategies during surgery.

02

Conditions studied

  • Craniosynostoses

Browse trials for

03

In context

Craniosynostoses

51 studies on the registry are indexed under Craniosynostoses; 14 are open to participants now.

This study's enrollment of 40 is close to the median of 43 across 26 observational studies indexed under Craniosynostoses.

Browse Craniosynostoses studies →

Lead sponsor

Hospices Civils de Lyon is the lead sponsor of 1,866 studies on the registry; 448 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
3 Months to 18 Months
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Children with craniosynostosis.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Boys and girls.
  • Aged 3 to 18 months old.
  • Subjects with a craniosynostosis diagnosis confirmed by imaging.
  • Craniosynostosis requiring a corrective surgery in ventral position.
  • Parents/ legal guardian must provide non opposition prior to participation in the study.

Exclusion criteria

Exclusion Criteria:

  • Craniosynostosis planned to be corrected by an endoscopic craniectomy or in dorsal position.
05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
40 participants (actual)
Patient registry
No

Groups and cohorts

  • Children with craniosynostosis

    Children with craniosynostosis who will be operated in prone position.

    Other: NIRS monitoring

Interventions

  • OtherNIRS monitoring

    Regional cerebral oxygen saturation (rScO₂) will be collected by NIRS monitoring before anesthesia induction, during surgery and after extubation, in children with craniosynostosis.

06

What researchers measure

Primary outcomes

  1. Regional cerebral oxygen saturation measure

    Variations of rScO₂ (%, frequency of desaturations) measured by NIRS captors

    Time frame: Day 0 before anesthesia

  2. Regional cerebral oxygen saturation measure

    Variations of rScO₂ (%, frequency of desaturations) measured by NIRS captors

    Time frame: Day 0 during surgery

  3. Regional cerebral oxygen saturation measure

    Variations of rScO₂ (%, frequency of desaturations) measured by NIRS captors

    Time frame: Day 0 after extubation

07

Study locations

1 site
  • Hospices Civils de Lyon service neurochirurgie pédiatrique
    Bron, 69500, France
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Feb 21, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT04086056
Responsible party
Sponsor
First posted
Sep 11, 2019
Start date
Jan 20, 2020
Primary completion
Oct 11, 2023
Completion
Oct 11, 2023
Last update
Feb 21, 2024

Study contacts

Federico DI ROCCO
principal investigator · Hospices Civils de Lyon service neurochirurgie pédiatrique

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Feb 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion